GL1X · GenesisL1 explorer

Research workbench

The structure of pantothenate synthetase from burkholderia thailandensis

Analyse The structure of pantothenate synthetase from burkholderia thailandensis in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3UK2
Type
protein
Length
560 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Pantothenate synthetase
EC
6.3.2.1
UniProt
Q2T095
Ligands
AMP, MLT, CL
Pockets
6 · best druggability 0.85

Structure

x-ray diffraction · 1 distinct chain · 41% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BPantothenate synthetase (EC 6.3.2.1)protein28041% helix, 19% strandQ2T095

Ligands and binding sites

  • AMP · Adenosine monophosphate · ligand · 2 copies · chains A, B
  • MLT · D-malate · ligand · 2 copies · chains A, B
  • CL · Chloride ion · ion · 4 copies · chains A, B
  • EDO · 1,2-ethanediol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14290.850.9366AMP, MLT, EDO
24390.840.9166AMP, MLT
36900.790.8466CL
4820.390.7716empty
5750.360.7716CL

Interfaces

1 interface between chains.

  • A–B · 1313 Ų buried · 22 hydrogen bonds · protein-protein

Compared structures

  • 3UK2 · The structure of Pantothenate synthetase from Burkholderia thailandensis · the same entry in another collection · chain A against A, TM-score 1.00
  • Q2T095 · AlphaFold monomer V2.0 prediction for pantothenate synthetase (Q2T095) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.